TrialClinical ophthalmology (Auckland, N.Z.)2022

The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial.

Mark PackerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.